Company Profile
Editorial
Awards
Management Team
Board of Directors
Employment
News
Investor Relations
Overview
Earnings Reports
FAQ
Information Request
 
 
Home » About A.D.A.M. » Investor Relations »

A.D.A.M. Announces Third Quarter Earnings of $0.05 Per Share
Revenues Increase 22%, Healthcare-Related Revenues Climb 47%

ATLANTA - (BUSINESS WIRE) - Nov. 3, 2004 - A.D.A.M., Inc. (Nasdaq: ADAM), a leading developer of interactive health information and decision support tools for the healthcare and education markets, today announced financial results for the third quarter ended September 30, 2004.

A.D.A.M., Inc. reported net income for the third quarter of 2004 of $405,000, or $0.05 per fully diluted share, as compared to net income of $86,000, or $0.01 per fully diluted share, in the year ago quarter. Revenues for the quarter ended September 30, 2004 were $2,278,000 compared to revenues of $1,873,000 in the year-ago period, an increase of approximately 22%.

A.D.A.M. reported net income for the nine-month period ended September 30, 2004 of $945,000, or $0.11 per fully diluted share, as compared to net income of $511,000, or $0.06 per fully diluted share, for the nine months ended September 30, 2003. Revenues for the nine-month period ended September 30, 2004 were $5,962,000 compared to revenues of $6,151,000 during the same period last year. The decrease in revenues for the nine-month period was due to the expiration of a content license agreement with WebMD Corp. that contributed approximately $600,000 of revenue in the first quarter of 2003.

Revenues from the Company's healthcare-related business increased approximately 47%, to $1,567,000 for the three months ended September 30, 2004 as compared to $1,063,000 for the year ago quarter. Revenues from healthcare represent approximately 69% of the Company's total revenues for the three-month period ended September 30, 2004.

On a sequential performance basis, revenues for the third quarter of 2004 increased approximately 18% as compared to the second quarter of 2004, net income increased approximately 29%, and cash and investments increased approximately 23%. As of September 30, 2004, the Company's cash and investments were $6,411,000, an increase of $1,857,000 as compared to $4,554,000 as of December 31, 2003.

Robert S. Cramer, Jr., A.D.A.M.'s Chairman and CEO, commented: "Our results today demonstrate A.D.A.M.'s ability to grow its business. With a number of new initiatives in place, and seven consecutive quarters of profitability behind us, we anticipate a strong year-end finish and believe we are well positioned for 2005."

Conference Call Information

A.D.A.M. will hold its third quarter earnings conference call today, November 3, 2004, at 10:00 A.M. ET. To participate in the call, please dial (877) 829-1372 approximately five minutes prior to the start time. International callers may dial (706) 679-8134.

Forward-Looking Statements

Except for historical information, all of the statements, expectations and assumptions contained in this press release are forward-looking statements. These statements, especially revenue, net income and cash flow forecasts, involve a number of risks and uncertainties that could cause actual results, performance or developments to differ materially. Factors that could affect the company's actual results, performance or developments include general economic conditions, development of the Internet as a source of health information, pricing actions taken by competitors, demand for the company's health information, and changes in laws and regulations that impact how the company conducts its business. A.D.A.M. disclaims any obligation or duty to update any of its forward-looking statements.

About A.D.A.M., Inc.

For more than a decade, A.D.A.M.'s unique, visually engaging health content, decision support tools and educational products have been helping millions of people "get smart" about their health and wellness. With one of the largest consumer-oriented medical information libraries in the world, A.D.A.M. markets its solutions to leading healthcare and pharmaceutical organizations, government, employers, and educational institutions. To learn more about A.D.A.M., visit www.adam.com or call 1-800-408-ADAM.

 
 
A.D.A.M., Inc.
 
Condensed Consolidated Statements of Operations and Summary Balance Sheet Data
(In thousands, except per share data)
(unaudited)

 
 
 
   
Three Months
Three Months
Nine Months
Nine Months
   
Ended
Ended
Ended
Ended
   
Sept. 30,2004
Sept. 30,2003
Sept. 30, 2004
Sept.30,2003
           
  Total Revenues
$2,278
$1,873
$5,962
$6,151
   
----------
----------
----------
----------
           
  Operating expenses:        
  Cost of revenues
457
420
1,185
1,296
  General and administrative
458
487
1,206
1,312
  Product and content development
407
281
1,007
1,124
  Sales and marketing
430
392
1,227
1,353
  Depreciation and amortization
146
217
443
588
   
----------
----------
----------
----------
  Total operating expenses
1,898
1,797
5,068
5,673
   
----------
----------
----------
----------
  Operating income (loss)
380
76
894
478
   
  Interest income (expense), net
25
10
51
33
   
----------
----------
----------
----------
   
  Income (loss) before losses from affiliate
97
(248)
608
(1,282)
   
----------
----------
----------
----------
  Net income
405
86
945
511
   
======
======
======
======
   
  Basic net income per common share
$0.05
$0.01
$0.12
$0.07
   
======
======
======
======
   
  Basic weighted average number of common shares outstanding
7,904
7,421
7,881
7,163
   
======
======
======
======
  Diluted net income per
common share
$0.05
$0.01
$0.11
$0.06
   
======
======
======
======
  Diluted weighted average number of common shares outstanding
8,735
8,325
8,649
7,973
   
======
======
======
======
           

 
Summary Balance Sheet Data
 
---------------------------------
 
9/30/2004
12/31/2003
 
----------
----------
Cash and cash equivalents
$2,686
$4,554
Accounts receivable-net
1,316
1,407
Investments, short term
2,725
-
Total current assets
7,196
6,355
Investments, long term
1,000
-
Goodwill
2,043
2,043
Total assets
1,273
10,496
Deferred revenue
2,854
2,295
Short term debt
12
11
Total current liabilities
3,612
2,940
Total liabilities
3,639
2,976
Shareholders' equity
8,434
7,520
Working capital
3,584
3,415

 

Victor Thompson
770-425-7877


 
     
Legal Notices | Editorial Policy | Privacy Statement
Contact A.D.A.M.
© 2006 A.D.A.M., Inc. All rights reserved.